What is Albumin?
Albumin is the most abundant protein in human plasma, making up approximately 60% of the body's total protein content. Produced exclusively by the liver, its primary roles include maintaining the colloid osmotic pressure (COP) to keep fluid within the blood vessels, transporting hormones, fatty acids, and drugs, and acting as a free radical scavenger.
Clinical Indications for Albumin Therapy
Albumin therapy is not a universal treatment for all cases of low albumin (hypoalbuminemia), as nutritional therapy is often more appropriate for chronic deficiencies. Instead, it is reserved for specific conditions where rapid volume expansion or correction of an acute deficiency is needed. Key clinical indications include liver cirrhosis complications, critical care situations, and specific medical conditions.
Comparing Albumin to Crystalloids
Healthcare providers weigh using albumin (a colloid) versus crystalloid solutions for fluid resuscitation. The choice is condition-dependent. Here is a comparison:
| Feature | Albumin (Colloid) | Crystalloids (e.g., Saline, Lactated Ringer's) | 
|---|---|---|
| Cost | Significantly more expensive. | Much less expensive and widely available. | 
| Primary Function | Increases plasma volume by drawing fluid into circulation via osmotic pressure. | Increases total body water and sodium, increasing plasma volume. | 
| Plasma Volume Expansion | More efficient volume expansion per unit. | Requires larger volumes; much shifts into interstitial space. | 
| Clinical Evidence | Strong for specific conditions like SBP and paracentesis. Limited for routine use in all critical care. | First-line for most resuscitation, with established evidence. | 
| Associated Risks | Potential for fluid overload, remote viral transmission risk. | Risk of hyperchloremic acidosis with large saline volumes. | 
Cautions and Monitoring
Due to cost and potential risks, albumin use is closely monitored. Patients, especially those with heart or kidney issues, need observation for fluid overload signs like high blood pressure, breathing difficulty, and swelling. For liver disease, specific monitoring ensures correct dosing and prevents complications.
Conclusion
Albumin is a valuable treatment for acute and critical conditions requiring rapid fluid balance restoration. It provides targeted support for complications of liver cirrhosis (like SBP and hepatorenal syndrome) and severe hypovolemia from burns or shock, guided by evidence. Clinicians must consider costs, benefits, and risks for each patient to determine appropriate use and optimize outcomes. For more information on evidence-based guidelines, consult resources like {Link: ScienceDirect https://www.sciencedirect.com/science/article/pii/S001236922400285X}.